1|Page
SOCRA CCRP EXAM NEWEST 2026 ACTUAL EXAM 200
QUESTIONS AND CORRECT DETAILED ANSWERS WITH
RATIONALES /SOCRA CCRP EXAM ACTUAL EXAM 200
QUESTIONS AND CORRECT DETAILED ANSWERS WITH
RATIONALES |AGRADE
Question 1
Which document outlines the ethical principles for research involving human
subjects in the United States?
A. Declaration of Helsinki
B. Belmont Report
C. Nuremberg Code
D. HIPAA Privacy Rule
Answer: B
Rationale: The Belmont Report establishes ethical principles including respect
for persons, beneficence, and justice.
Question 2
What is the primary purpose of informed consent in clinical research?
A. Protect sponsors from lawsuits
B. Ensure subjects voluntarily understand study participation
C. Replace IRB review
D. Guarantee study success
pg. 1
,2|Page
Answer: B
Rationale: Informed consent ensures participants understand risks, benefits, and
rights before enrolling.
Question 3
Which phase of a clinical trial primarily evaluates drug safety in healthy
volunteers?
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
Answer: A
Rationale: Phase I trials focus on safety, dosage, and pharmacokinetics.
Question 4
Under ICH-GCP guidelines, who is ultimately responsible for the conduct of a
clinical trial at a site?
A. Sponsor
B. Study coordinator
C. Principal investigator
D. Monitor
Answer: C
Rationale: The principal investigator is responsible for overall study conduct at
the site.
pg. 2
,3|Page
Question 5
Which action requires prior IRB approval before implementation?
A. Correcting typographical errors in source notes
B. Protocol amendments affecting subjects
C. Routine monitoring visits
D. Drug shipment tracking
Answer: B
Rationale: Protocol changes impacting participants require IRB approval before
implementation unless necessary for immediate safety.
Question 6
What is the purpose of source documentation in clinical research?
A. Replace case report forms
B. Provide original records supporting study data
C. Eliminate monitoring visits
D. Prevent informed consent
Answer: B
Rationale: Source documents verify accuracy and authenticity of study data.
Question 7
Which term describes any unfavorable medical occurrence in a study
participant?
pg. 3
, 4|Page
A. Protocol deviation
B. Serious violation
C. Adverse event
D. Monitoring exception
Answer: C
Rationale: An adverse event is any unfavorable medical occurrence during a
clinical trial.
Question 8
A serious adverse event must generally be reported to the sponsor within what
timeframe?
A. Immediately or according to protocol requirements
B. Within 6 months
C. Only at study completion
D. Reporting is optional
Answer: A
Rationale: SAE reporting timelines are specified in protocol and regulatory
requirements.
Question 9
Which organization is responsible for protecting the rights and welfare of
research participants?
A. IRB
B. Sponsor only
pg. 4
SOCRA CCRP EXAM NEWEST 2026 ACTUAL EXAM 200
QUESTIONS AND CORRECT DETAILED ANSWERS WITH
RATIONALES /SOCRA CCRP EXAM ACTUAL EXAM 200
QUESTIONS AND CORRECT DETAILED ANSWERS WITH
RATIONALES |AGRADE
Question 1
Which document outlines the ethical principles for research involving human
subjects in the United States?
A. Declaration of Helsinki
B. Belmont Report
C. Nuremberg Code
D. HIPAA Privacy Rule
Answer: B
Rationale: The Belmont Report establishes ethical principles including respect
for persons, beneficence, and justice.
Question 2
What is the primary purpose of informed consent in clinical research?
A. Protect sponsors from lawsuits
B. Ensure subjects voluntarily understand study participation
C. Replace IRB review
D. Guarantee study success
pg. 1
,2|Page
Answer: B
Rationale: Informed consent ensures participants understand risks, benefits, and
rights before enrolling.
Question 3
Which phase of a clinical trial primarily evaluates drug safety in healthy
volunteers?
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
Answer: A
Rationale: Phase I trials focus on safety, dosage, and pharmacokinetics.
Question 4
Under ICH-GCP guidelines, who is ultimately responsible for the conduct of a
clinical trial at a site?
A. Sponsor
B. Study coordinator
C. Principal investigator
D. Monitor
Answer: C
Rationale: The principal investigator is responsible for overall study conduct at
the site.
pg. 2
,3|Page
Question 5
Which action requires prior IRB approval before implementation?
A. Correcting typographical errors in source notes
B. Protocol amendments affecting subjects
C. Routine monitoring visits
D. Drug shipment tracking
Answer: B
Rationale: Protocol changes impacting participants require IRB approval before
implementation unless necessary for immediate safety.
Question 6
What is the purpose of source documentation in clinical research?
A. Replace case report forms
B. Provide original records supporting study data
C. Eliminate monitoring visits
D. Prevent informed consent
Answer: B
Rationale: Source documents verify accuracy and authenticity of study data.
Question 7
Which term describes any unfavorable medical occurrence in a study
participant?
pg. 3
, 4|Page
A. Protocol deviation
B. Serious violation
C. Adverse event
D. Monitoring exception
Answer: C
Rationale: An adverse event is any unfavorable medical occurrence during a
clinical trial.
Question 8
A serious adverse event must generally be reported to the sponsor within what
timeframe?
A. Immediately or according to protocol requirements
B. Within 6 months
C. Only at study completion
D. Reporting is optional
Answer: A
Rationale: SAE reporting timelines are specified in protocol and regulatory
requirements.
Question 9
Which organization is responsible for protecting the rights and welfare of
research participants?
A. IRB
B. Sponsor only
pg. 4
